INCOME TAX (Tables)
|
12 Months Ended |
Mar. 31, 2026 |
| Income Taxes [Abstract] |
|
| Major items causing the income tax rate to differ from the Canadian statutory rate |
Major items causing the Company’s income tax rate to differ from the Canadian statutory rate of approximately 26.5% are as follows: | | | | | | | | | | | | | | | | | Year ended March 31, | | | | 2026 | 2025 | | | | | Restated - Note 2 | | | | $ | $ | | Net loss before income taxes | | | (147,998) | | (81,607) | | | | | | | Expected recovery at statutory rate | | | 39,219 | | 21,626 | | Share-based compensation | | | (685) | (7,572) | | Share issuance costs | | | 2,806 | 88 | | Difference between Canadian and foreign tax rates | | | (16,438) | (6,720) | | Effect of exchange on unbooked deferred tax assets | | | 816 | 253 | | Non-deductible expenses | | | (124) | (75) | | Change in unrecognized deferred tax assets | | | (25,594) | (7,600) | | Income tax recovery | | | — | — |
|
| Significant components of deferred tax assets |
The significant components of the Company’s deferred tax assets resulting from temporary differences, unused tax credits and unused tax losses, that have not been included on the consolidated statement of financial position, are as follows: | | | | | | | | | | As at | March 31, 2026 | March 31, 2025 | | | Restated - Note 2 | | $ | $ | | Non-capital loss carryforwards - Canada | 24,906 | 15,518 | | Non-capital loss carryforwards - United States | 2,715 | 1,762 | | Non-capital loss carryforwards - Ireland | 25,448 | 12,748 | | Non-capital loss carryforwards - United Kingdom | 8,374 | 7,489 | | Deferred compensation | 526 | 1,150 | | Research and development expenditures | 2,680 | 1,765 | | Share issuance costs | 3,546 | 2,158 | | Depreciation/capital cost allowance differences | (1) | 10 | | 68,194 | 42,600 | | Valuation allowance | (68,194) | (42,600) | | — | — |
|
| Non-capital losses expiration |
The non-capital losses, stated in U.S. dollars, expire as follows: | | | | | | | Year of expiry | $ | | 2036 | 1 | | 2037 | 44 | | 2038 | 23 | | 2039 | 83 | | 2040 | 619 | | 2041 | 15,679 | | 2042 | 11,492 | | 2043 | 7,679 | | 2044 | 17,502 | | 2045 | 7,272 | | 2046 | 33,588 | | 93,982 |
The Massachusetts non-capital losses expire as follows: | | | | | | | Year of expiry | $ | | 2040 | 733 | | 2041 | 1,074 | | 2042 | 3,461 | | 2043 | 1,108 | | 2044 | 991 | | 2045 | 4,589 | | 2046 | 8,490 | | 20,446 |
The non-capital losses in Ireland, stated in U.S. Dollars, expire as follows: | | | | | | | Year of expiry | $ | 2042 | 16,475 | 2043 | 16,512 | 2044 | 24,289 | | 2045 | 41,520 | 2046 | 92,029 | | 190,825 |
|